How Much Do Peptides Cost? Do the Milligram Math

Peptide pricing looks arbitrary until you understand what you’re actually paying for, at which point it becomes fairly legible. A vial can run under ten dollars or well over a hundred, and the spread isn’t mostly about brand.

This covers what drives peptide cost, why comparing sticker prices between vendors is close to useless, and how to work out cost per milligram so you’re comparing the same thing. Current prices for every compound sit on the individual product pages, because quoting them in an article guarantees the article goes stale. What doesn’t go stale is the reasoning.

How much do peptides cost: the honest range

For research-grade compounds sold by the vial, most of the market sits somewhere between roughly ten dollars and a hundred and fifty. Bacteriostatic water and simple short peptides anchor the low end. Multi-compound blends and larger vials of the metabolic compounds sit at the top.

That range is wide enough to be almost unhelpful, which is the point. Asking what peptides cost is a bit like asking what a bottle of wine costs. The answer depends on which one, how much is in it, and whether anyone has verified the label.

What’s more useful is understanding the four things that actually move the number.

What actually drives peptide cost

Sequence length is the first and largest factor. Peptides are built one amino acid at a time in solid-phase synthesis, and every added residue is another coupling step with its own yield loss and its own reagent cost. A tripeptide like KPV is three residues. Semaglutide is thirty-one, with modifications. That difference compounds through the whole process.

Modifications are the second. Attaching a fatty acid chain, adding a copper ion, or capping a terminus each requires additional chemistry. GHK-Cu is only three residues but carries a coordinated copper, which is its own step.

Vial mass is the third and the one buyers most often ignore. A 10mg vial and a 5mg vial of the same compound are not the same product, and comparing their prices directly is a category error.

Testing is the fourth. HPLC purity analysis plus mass spectrometry identity confirmation on every batch, from an independent laboratory, costs money per batch. A vendor skipping it has a real cost advantage, which is worth remembering when a price looks impossibly good.

Peptide cost per milligram: the only fair comparison

Sticker price tells you almost nothing across vendors, because vial sizes differ. Cost per milligram is the comparison that means something.

The arithmetic is one division. Take the price, divide by the milligrams in the vial. A 10mg vial at $60 is $6 per mg. A 5mg vial at $35 is $7 per mg. The second vial looks cheaper on the shelf and is more expensive in reality.

This is the single most common way people overpay in this category, and it isn’t subtle once you start doing it. Some vendors lean on it deliberately by listing smaller vials at attractive-looking prices.

Blends need the same treatment with an extra step. KLOW 80 contains four compounds at different masses, so a per-mg figure across the whole vial is a blended average rather than a price for any one component. The peptide calculator breaks blends down component by component if you want to see the split.

Why peptide prices vary so much between vendors

Three vendors selling the same compound at three prices are usually doing three different things.

The cheapest is often skipping independent testing, or testing one batch and publishing that certificate against every subsequent batch. It’s a real saving and it transfers the risk to the buyer, who has no way to detect it without testing the vial independently.

The mid-range typically reflects per-batch testing with a published certificate, US-based shipping, and a business with overheads. That’s most of what separates it from the bottom.

The premium tier sometimes reflects genuinely tighter specifications and sometimes reflects branding. Distinguishing those requires reading certificates rather than reading price tags, which is inconvenient and unavoidable.

Why the cheapest peptides are usually the expensive ones

A vial that costs half the market rate is making that money back somewhere.

Lower purity is the usual answer. A compound at 92% purity is 8% something else, and that something else is synthesis byproducts, truncated sequences, and residual solvents that nobody has characterized. It isn’t inert filler.

Underfilled vials are the second answer, and they’re invisible without a scale sensitive enough to weigh milligrams. A vial labeled 10mg containing 7mg is a 30% price increase disguised as a discount.

The third is a certificate that doesn’t correspond to the vial. A real-looking PDF with a lot number that matches nothing is cheap to produce and impossible to disprove without independent testing.

None of that is hypothetical, and it’s why the certificate question sits ahead of the price question rather than beside it.

Peptide cost by category: what to expect

Category	Typical relative cost	Why
Bacteriostatic water	Lowest	Not a peptide, simple formulation, no synthesis
Short peptides (3 to 10 residues)	Low to moderate	Few coupling steps, higher yield
Mid-length peptides	Moderate	More steps, more yield loss
Long or modified peptides	Higher	Length plus lipidation or other modification
Multi-compound blends	Highest per vial	Several compounds, several tests, higher total mass

Blends look expensive per vial and often aren’t per milligram, because you’re buying several compounds at once. Whether that’s good value depends entirely on whether you’d have bought all of them separately.

The costs people forget to budget for

The vial isn’t the whole spend, and the extras catch first-time buyers out.

Bacteriostatic water is required for reconstitution and is a separate purchase. It’s inexpensive, and forgetting it means a vial sitting unusable.

Syringes are a separate purchase too. Storage matters, since lyophilized compounds generally want cold storage and reconstituted solutions have a shorter usable window, which is covered in how to store peptides.

Then there’s the cost nobody prices in: a vial that turns out to be the wrong compound is a total loss, not a partial one. That’s the real argument for paying slightly more for verified material rather than the ethical one.

How to compare peptide costs across suppliers without guessing

Four steps, in order, and the price step is last.

Confirm the vial mass, since the label and the product title occasionally disagree. Find the batch certificate and confirm it exists before purchase rather than on request. Check that the lot number on the certificate matches the vial you’d receive, and that purity is stated by HPLC with identity confirmed by mass spectrometry. Then divide price by milligrams.

Doing it in that order means you’re comparing verified material to verified material. Doing it in reverse means you’re comparing a known price to an unknown compound, which is how most of this market operates.

Our certificates are published on each product page before purchase, and every batch certificate is collected in one place. How to read a certificate of analysis walks through which figures prove something, and how to choose a peptide supplier details the rest of the checklist.

Why peptide cost has fallen, and where it hasn’t

Solid-phase peptide synthesis has been around since Merrifield’s work in the 1960s, and the method has been refined continuously since. Automated synthesisers, better coupling reagents, and improved purification have all pushed the cost of routine peptides down substantially over the past two decades.

Short, unmodified sequences benefited most. A tripeptide is close to a commodity now, which is why compounds like GHK-Cu and KPV sit at the accessible end of the market despite decades of research behind them.

Long, modified peptides haven’t followed the same curve. Each additional residue multiplies the opportunities for a coupling step to fail, and yields fall accordingly. A thirty-residue sequence with a lipid modification involves purification challenges that automation hasn’t solved. That’s the structural reason the metabolic compounds cost what they do, and it isn’t going to change quickly.

Supply and demand adds a layer on top. Compounds with high public interest see price pressure from both directions: more suppliers entering, and more demand chasing limited synthesis capacity. Retatrutide has been a clear example of that since its trial data started circulating.

Peptide cost and the price-per-research-question view

There’s a framing that’s more useful than cost per vial or even cost per milligram, and almost nobody applies it.

What does the research question cost to answer properly? If it needs a compound plus bacteriostatic water plus consumables plus enough material to run more than one condition, the vial price is a fraction of it. Buying the cheapest vial and running out halfway through is more expensive than buying adequately once.

The same logic applies to blends. GLOW 70 costs more per vial than a single compound and less than buying its three components separately, which makes it good value if the question genuinely calls for all three and poor value if it doesn’t. The vial price answers neither question on its own.

And the failure mode nobody budgets for is the untested vial. A compound that turns out to be wrong doesn’t cost you the price difference you saved. It costs you the whole purchase plus whatever time went into the work built on top of it.

How much do peptides cost: frequently asked questions

How much do peptides cost per vial?

Most research-grade vials fall between roughly ten dollars and a hundred and fifty, depending on sequence length, modifications, vial mass and whether independent batch testing is included. Current prices for each compound are on the individual product pages.

Why are some peptides so much more expensive than others?

Longer sequences need more synthesis steps, each with its own yield loss. Modifications such as lipidation or a coordinated metal ion add further steps. Vial mass and per-batch independent testing also affect the figure.

How do I compare peptide prices between suppliers?

Divide price by the milligrams in the vial to get cost per milligram. Sticker prices are not comparable across suppliers because vial sizes differ.

Are cheap peptides worth buying?

A price well below market rate is usually recovering the difference somewhere: lower purity, underfilled vials, or a certificate that does not correspond to the batch. None of those are detectable without independent testing.

Are peptide blends cheaper than buying compounds separately?

Often, on a per-milligram basis, because several compounds ship in one vial with one reconstitution. That is only a saving if the research question actually calls for all of the components.

What else needs buying alongside a peptide vial?

Bacteriostatic water for reconstitution and syringes, both sold separately. Cold storage is also a practical requirement for lyophilized material.

Does cost indicate peptide quality?

Only loosely. A price well below market usually signals a corner cut somewhere, but a high price does not by itself demonstrate anything. Purity figures, identity confirmation and a matching lot number are evidence. Price is not.

Why do the same peptides cost different amounts at different vendors?

Vial mass differs, testing practice differs, and some vendors publish a single certificate against many batches. Comparing cost per milligram between suppliers who both test per batch is the only comparison that holds.

Price is the last question, not the first

Cost per milligram is the number worth calculating, and it only means anything once you know the vial contains what the label says. A cheap vial of the wrong compound isn’t a bargain in any sense.

Work through the certificate first, then the arithmetic. Every compound in the shop carries a published batch certificate, which is the part of the price you can actually verify.